Home / Executive Moves / Randy Phillips Named Leidos Corporate Dev’t SVP; James Reagan Comments

Randy Phillips Named Leidos Corporate Dev’t SVP; James Reagan Comments

Randy Phillips

Randy Phillips, senior vice president for corporate development at Ellucian, has joined Leidos (NYSE: LDOS) in the same capacity.

He will oversee Leidos’ strategic growth and development efforts through mergers and acquisitions, the company said Monday.

“Phillips has been guiding transactions in our sector for many years, helping to define the market in the process,” said James Reagan, executive VP and chief financial officer at Leidos.

“He understands where the growth in our market will be and how to create the growth strategies that will help ensure Leidos is well-positioned in the coming years,” added Reagan, a three-time Wash100 recipient.

Phillips brings to Leidos more than three decades of experience in corporate development at several technology firms such as Boeing (NYSE: BA), TRW, Alcoa and Computer Sciences Corp.

He has led deals worth approximately $40 billion in combined value in 20 countries and has served as a strategic adviser to private equity firms and advisory companies such as KKR, TPG, General Atlantic, Leonard Green Partners and The Chertoff Group.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.